A comparison between histological grade and nuclear morphometry for predicting the clinical outcome of localized renal cell carcinoma

被引:23
作者
Nativ, O [1 ]
Sabo, E [1 ]
Bejar, J [1 ]
Halachmi, S [1 ]
Moskovitz, B [1 ]
Miselevich, I [1 ]
机构
[1] BNAI ZION MED CTR,DEPT PATHOL,HAIFA,ISRAEL
来源
BRITISH JOURNAL OF UROLOGY | 1996年 / 78卷 / 01期
关键词
renal cell carcinoma; grade; morphometry; prognosis;
D O I
10.1046/j.1464-410X.1996.00447.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives To determine the interrelationship of histological grade and nuclear morphometry and to compare their prognostic significance in patients with localized renal cell carcinoma (RCC). Patients and methods A retrospective prognostic study of 39 patients with localized (pT1, pT2) RCC was performed, Conventional histological grade and nuclear morphometry were assessed independently and the correlation between these grading systems and their impact on the patients' outcome were evaluated. Results Histological grade and the nuclear morphometric variables were significantly correlated; the strongest association was that between grade and the nuclear regularity factor. The best predictor of disease-free interval and survival (by univariate analysis) was the combination of nuclear area and nuclear elongation factor, followed by conventional tumour grade, nuclear elongation factor, nuclear regularity factor and nuclear area. However, a multivariate analysis showed that the only independent prognosticator for survival was the combination of nuclear area and nuclear elongation factor. Conclusions This study indicates that nuclear morphometry is prognostically superior to histological grade in patients with localized RCC.
引用
收藏
页码:33 / 38
页数:6
相关论文
共 24 条
  • [1] BEAHRS OH, 1992, AM JOINT COMMITTEE C, P201
  • [2] HUMAN RENAL-CARCINOMA LINE TRANSFECTED WITH INTERLEUKIN-2 AND OR INTERFERON-ALPHA GENE(S) - IMPLICATIONS FOR LIVE CANCER VACCINES
    BELLDEGRUN, A
    TSO, CL
    SAKATA, T
    DUCKETT, T
    BRUNDA, MJ
    BARSKY, SH
    CHAI, J
    KABOO, R
    LAVEY, RS
    MCBRIDE, WH
    DEKERNION, JB
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (03) : 207 - 216
  • [3] BOT FJ, 1994, INT J CANCER, V57, P634
  • [4] COX DR, 1972, J R STAT SOC B, V34, P187
  • [5] THE VALUE OF HISTOQUANTITATIVE MEASUREMENTS IN PROGNOSTIC ASSESSMENT OF RENAL ADENOCARCINOMA
    ESKELINEN, M
    LIPPONEN, P
    AITTOOJA, L
    HALL, O
    SYRJANEN, K
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1993, 55 (04) : 547 - 554
  • [6] DNA AND PCNA CONTENT OF RENAL-CELL CARCINOMA AND PROGNOSIS
    FLINT, A
    GROSSMAN, HB
    LIEBERT, M
    LLOYD, RV
    BROMBERG, J
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1995, 103 (01) : 14 - 19
  • [7] PROGNOSTIC-SIGNIFICANCE OF MORPHOLOGIC PARAMETERS IN RENAL-CELL CARCINOMA
    FUHRMAN, SA
    LASKY, LC
    LIMAS, C
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1982, 6 (07) : 655 - 663
  • [8] NUCLEAR MORPHOMETRY IN PROGNOSIS OF RENAL ADENOCARCINOMA
    GUTIERREZ, JL
    VALBERNAL, JF
    GARIJO, MF
    BUELTA, L
    PORTILLO, JA
    [J]. UROLOGY, 1992, 39 (02) : 130 - 134
  • [9] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS
    KAPLAN, EL
    MEIER, P
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) : 457 - 481
  • [10] RENAL-CELL CARCINOMA - LONG-TERM SURVIVAL AND LATE RECURRENCE
    MCNICHOLS, DW
    SEGURA, JW
    DEWEERD, JH
    [J]. JOURNAL OF UROLOGY, 1981, 126 (01) : 17 - 23